3-(4-Bromophenyl)-5-(chloromethyl)-1,2,4-oxadiazole

Catalog No. :
ACYOZU642
CAS No. :
110704-42-2
Molecular Formula :
C9H6BrClN2O
Molecular Weight :
273.52

IUPAC Name:3-(4-bromophenyl)-5-(chloromethyl)-1,2,4-oxadiazole

3-(4-Bromophenyl)-5-(chloromethyl)-1,2,4-oxadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$55.00Login to see priceIn stockIn stock
1g98%$134.00Login to see priceIn stockIn stock
5g98%$408.00Login to see priceIn stockIn stock
25g98%$1979.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4-Bromophenyl)-5-(chloromethyl)-1,2,4-oxadiazole
IUPAC Name3-(4-bromophenyl)-5-(chloromethyl)-1,2,4-oxadiazole
MDL No.MFCD08445385
Molecular FormulaC9H6BrClN2O
Molecular Weight273.52
SMILESClCC1=NC(=NO1)C1=CC=C(Br)C=C1
InChI KeyQBGZOSPLOUPRQG-UHFFFAOYSA-N
Synonym3-(4-bromophenyl)-5-(chloromethyl)-1,2,4-oxadiazole | 110704-42-2 | SCHEMBL10937283 | DTXSID30550008 | MFCD08445385 | STK695913 | AKOS000111836 | AB45283 | LC-0712 | BB 0242360 | FT-0681187 | J-510660 | 3-(4-Bromo-phenyl)-5-chloromethyl-[1,2,4]ox adiazole
CAS No.110704-42-2
PubChem CID13805069

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACYOZU642 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYOZU642 route product structure diagram
    ACYOZU642110704-42-2 In Stock
Inquiry

2. ACYOZU642 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYOZU642 route product structure diagram
    ACYOZU642110704-42-2 In Stock
Inquiry

Comments (0)